Residual Invasive Breast Cancer

Also known as: Invasive, residual Breast Cancer

DrugDrug NameDrug Description
DB05773Trastuzumab emtansineAn antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer.
DrugDrug NamePhaseStatusCount
DB00072Trastuzumab3Active Not Recruiting1
DB14962Trastuzumab deruxtecan3Active Not Recruiting1
DB05773Trastuzumab emtansine3Active Not Recruiting1